Evidence map›Paper›PMID 26322016›Full record

ReviewFrontiers in endocrinology2015

Two Birds with One Stone: Possible Dual-Role of Oxytocin in the Treatment of Diabetes and Osteoporosis.

Seham Elabd, Ismail Sabry

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Heliyon · 2024
    Article
  4. Article
  5. Review
  6. Ameliorative Effect of Oxytocin onFrontiers in public health · 2022
    Article
  7. TRPV1, Nrf2, and COVID-19: Could Oxytocin Have a Beneficial Role to Play?International archives of allergy and immunology · 2022
    Article
  8. Review
  9. Oxytocin and Bone: Review and Perspectives.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Metabolic Effects of Oxytocin.Endocrine reviews · 2020
    Review
  12. Review
  13. Article
  14. Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions.Clinical medicine insights. Endocrinology and diabetes · 2019
    Review
  15. Review
  16. Review
  17. Analysis ofFrontiers in physiology · 2018
    Article
  18. Review
  19. 17PeerJ · 2017
    Article
  20. An overview of the oxytocin-oxytocin receptor signaling network.Journal of cell communication and signaling · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Seham ElabdHuman Physiology Department, Medical Research Institute, Alexandria University , Alexandria , Egypt.
Ismail SabryZoology Department, Faculty of Science, Alexandria University , Alexandria , Egypt.
Alexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxytocin (OT), a hormone most commonly associated with labor and lactation, may have a wide variety of physiological and pathological functions, which makes OT and its receptor potential targets for drug therapy. In this review, we highlight the newly discovered metabolic role of OT in diabetes and its complication, such as diabetic osteopathy. OT may have positive metabolic effects; this is based on the change in glucose metabolism, lipid profile, and insulin sensitivity. It may modify glucose uptake and insulin sensitivity both through direct and indirect effects. It may also cause regenerative changes in diabetic pancreatic islet cells. Moreover, it has an anabolic effect on the bone biology. So, the activation of the OT receptor pathway by infusion of OT, OT analogs, or OT agonists may represent a promising approach for the treatment of diabetes and some of its complications, including diabetic osteopathy.

Indexed as

bone formationbone resorptiondiabetesglucose uptakeinsulin sensitivityosteoporosisoxytocin

Identifiers

PMID26322016
PMCPMC4530313
OpenAlexW1525093666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.